The effects of vitamin D supplementation on inflammatory biomarkers in patients with abnormal glucose homeostasis: a systematic review and meta-analysis of randomized controlled trials.
暂无分享,去创建一个
[1] S. Walrand,et al. Effect of Vitamin D Supplementation on Inflammatory Markers in Non-Obese Lebanese Patients with Type 2 Diabetes: A Randomized Controlled Trial , 2020, Nutrients.
[2] F. Rafiei,et al. The effects of chromium and vitamin D3 co-supplementation on insulin resistance and tumor necrosis factor-alpha in type 2 diabetes: a randomized placebo-controlled trial. , 2020, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[3] Sean M. Hartig,et al. Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice , 2020, Hepatology.
[4] L. Janani,et al. Vitamin D3 Supplementation in Diarrhea-Predominant Irritable Bowel Syndrome Patients: The Effects on Symptoms Improvement, Serum Corticotropin-Releasing Hormone, and Interleukin-6 – A Randomized Clinical Trial , 2020, Complementary Medicine Research.
[5] M. Clerici,et al. Vitamin D Supplementation is Associated with Increased Glutathione Peroxidase-1 Levels in Arab Adults with Prediabetes , 2020, Antioxidants.
[6] H. Poustchi,et al. Soy isoflavones and cholecalciferol reduce inflammation, and gut permeability, without any effect on antioxidant capacity in irritable bowel syndrome: A randomized clinical trial. , 2019, Clinical nutrition ESPEN.
[7] M. Djalali,et al. Effects of vitamin D supplementation on advanced glycation end products signaling pathway in T2DM patients: a randomized, placebo-controlled, double blind clinical trial , 2019, Diabetology & Metabolic Syndrome.
[8] J. Nelson,et al. Effect of vitamin D supplementation on cardiovascular risk in type 2 diabetes. , 2019, Clinical nutrition.
[9] K. Azizbeigi,et al. Anti-inflammatory effects of vitamin D and resistance training in men with type 2 diabetes mellitus and vitamin D deficiency: a randomized, double-blinded, placebo-controlled clinical trial , 2019, Journal of Diabetes & Metabolic Disorders.
[10] M. Jafarabadi,et al. Vitamin D supplementation has no effect on matrix metalloproteinases-2, -9, and tissue inhibitor matrix metalloproteinase-1 in subjects with metabolic syndrome: A pilot study. , 2019, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.
[11] Shi-kun Yang,et al. Effects of Vitamin D Supplementation on Renal Function, Inflammation and Glycemic Control in Patients with Diabetic Nephropathy: a Systematic Review and Meta-Analysis , 2019, Kidney and Blood Pressure Research.
[12] M. Vasson,et al. Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial , 2019, Front. Immunol..
[13] A. Rigby,et al. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome , 2019, Nutrients.
[14] M. Mobasseri,et al. The effects of vitamin D3 supplementation on some metabolic and inflammatory markers in diabetic nephropathy patients with marginal status of vitamin D: A randomized double blind placebo controlled clinical trial. , 2019, Diabetes & metabolic syndrome.
[15] S. Anton,et al. Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis , 2018, Ageing Research Reviews.
[16] R. Amani,et al. The effects of supplementation with vitamin D on inflammatory biomarkers, omentin, and vaspin in women with type 2 diabetes: A randomized double‐blind placebo‐controlled clinical trial , 2018, Journal of Food Biochemistry.
[17] Gang Huang,et al. Dichloroacetic acid (DCA) synergizes with the SIRT2 inhibitor Sirtinol and AGK2 to enhance anti-tumor efficacy in non-small cell lung cancer , 2018, Cancer biology & therapy.
[18] Guowei Huang,et al. Effect of Vitamin D Supplementation on Some Inflammatory Biomarkers in Type 2 Diabetes Mellitus Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2018, Annals of Nutrition and Metabolism.
[19] B. de Courten,et al. Vitamin D supplementation for improvement of chronic low‐grade inflammation in patients with type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials , 2018, Nutrition reviews.
[20] S. Chandrashekara,et al. Effect of vitamin D supplementation on reduction of cardiometabolic risk in patients with type 2 diabetes mellitus and dyslipidemia , 2018, International Journal of Diabetes in Developing Countries.
[21] F. Kolahdooz,et al. The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2018, Hormone and Metabolic Research.
[22] L. Janani,et al. A double blind randomized clinical trial to investigate the effect of vitamin D supplementation on metabolic and hepato-renal markers in type 2 diabetes and obesity , 2018, Medical journal of the Islamic Republic of Iran.
[23] M. Mazidi,et al. Impact of vitamin D supplementation on C-reactive protein; a systematic review and meta-analysis of randomized controlled trials , 2018, BMC Nutrition.
[24] B. de Courten,et al. Effects of vitamin D supplementation on inflammatory markers in heart failure: a systematic review and meta-analysis of randomized controlled trials , 2018, Scientific Reports.
[25] Y. Shang,et al. Vitamin D reduces inflammatory response in asthmatic mice through HMGB1/TLR4/NF-κB signaling pathway , 2017, Molecular medicine reports.
[26] Z. Asemi,et al. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome , 2017, Nutrients.
[27] L. Janani,et al. Can coenzyme Q10 supplementation effectively reduce human tumour necrosis factor-α and interleukin-6 levels in chronic diseases? Protocol for a systematic review and meta-analysis of randomised controlled trials , 2017, BMJ Open.
[28] Z. Asemi,et al. Note of Concern: Clinical Trial on the Effects of Vitamin D Supplementation on Metabolic Profiles in Diabetic Hemodialysis , 2018, Hormone and Metabolic Research.
[29] Z. Asemi,et al. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial , 2017, Hormone and Metabolic Research.
[30] M. Jafarabadi,et al. The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial , 2017, Endocrine.
[31] Yun Zhao,et al. The impact of cholecalciferol supplementation on the systemic inflammatory profile: a systematic review and meta-analysis of high-quality randomized controlled trials , 2017, European Journal of Clinical Nutrition.
[32] D. Dupont,et al. Dairy products and inflammation: A review of the clinical evidence , 2017, Critical reviews in food science and nutrition.
[33] R. Razzaghi,et al. The effects of vitamin D supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial. , 2017, Journal of diabetes and its complications.
[34] Ahmad Esmaillzadeh,et al. Long-Term Vitamin D Supplementation Affects Metabolic Status in Vitamin D-Deficient Type 2 Diabetic Patients with Coronary Artery Disease. , 2017, The Journal of nutrition.
[35] P. Bogdański,et al. The effect of vitamin D supplementation on selected inflammatory biomarkers in obese and overweight subjects: a systematic review with meta-analysis , 2016, European Journal of Nutrition.
[36] C. Catalano,et al. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial , 2016, BMC Medicine.
[37] L. Rosella,et al. Effect of Vitamin D3 Supplementation on Inflammatory Markers and Glycemic Measures among Overweight or Obese Adults: A Systematic Review of Randomized Controlled Trials , 2016, PloS one.
[38] B. de Courten,et al. Effect of vitamin D supplementation on inflammation: protocol for a systematic review , 2016, BMJ Open.
[39] M. Tambuwala. Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease , 2016, Inflammatory bowel diseases.
[40] F. Siddiqui,et al. A randomised controlled trial evaluating the impact of targeted vitamin D supplementation on endothelial function in type 2 diabetes mellitus: The DIMENSION trial , 2016, Diabetes & vascular disease research.
[41] Wei-Long Jiang,et al. Vitamin D Supplementation in the Treatment of Chronic Heart Failure: A Meta‐analysis of Randomized Controlled Trials , 2016, Clinical cardiology.
[42] A. H. Rasool,et al. Effects of 1α‐Calcidol (Alfacalcidol) on Microvascular Endothelial Function, Arterial Stiffness, and Blood Pressure in Type II Diabetic Nephropathy Patients , 2016, Microcirculation.
[43] G. Hitman,et al. Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double‐blind placebo‐controlled trial , 2016, Diabetes, obesity & metabolism.
[44] Ahmad Esmaillzadeh,et al. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D‐deficient women with polycystic ovary syndrome: a randomized double‐blind placebo‐controlled clinical trial , 2015, Clinical endocrinology.
[45] A. Slusher,et al. A therapeutic role for vitamin D on obesity-associated inflammation and weight-loss intervention , 2015, Inflammation Research.
[46] M. Uusitupa,et al. Glucose Metabolism Effects of Vitamin D in Prediabetes: The VitDmet Randomized Placebo-Controlled Supplementation Study , 2015, Journal of diabetes research.
[47] A. Goldfine,et al. Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease. , 2015, Journal of diabetes and its complications.
[48] S. Mousa,et al. Effect of Vitamin D Supplementation on Glucose Control and Inflammatory Response in Type II Diabetes: A Double Blind, Randomized Clinical Trial , 2015, International journal of endocrinology and metabolism.
[49] A. Sadiya,et al. Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial , 2014, European Journal of Clinical Nutrition.
[50] Ahmad Esmaillzadeh,et al. Calcium-vitamin D cosupplementation influences circulating inflammatory biomarkers and adipocytokines in vitamin D-insufficient diabetics: a randomized controlled clinical trial. , 2014, The Journal of clinical endocrinology and metabolism.
[51] L. Rejnmark,et al. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial. , 2014, Metabolism: clinical and experimental.
[52] S. Ghavamzadeh,et al. The Effect of Vitamin D Supplementation on Adiposity, Blood Glycated Hemoglobin, Serum Leptin and Tumor Necrosis Factor-α in Type 2 Diabetic Patients , 2014, International journal of preventive medicine.
[53] O. Ryu,et al. The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes , 2014, The Korean journal of internal medicine.
[54] I. Njølstad,et al. No Effect of High-Dose Vitamin D Supplementation on Glycemic Status or Cardiovascular Risk Factors in Subjects With Prediabetes , 2014, Diabetes Care.
[55] M. Davidson,et al. Effect of Long Term Vitamin D Supplementation on Biomarkers of Inflammation in Latino and African-American Subjects with Pre-Diabetes and Hypovitaminosis D , 2014, Hormone and Metabolic Research.
[56] Zeng-li Zhang,et al. Effect of Vitamin D Supplementation on the Level of Circulating High-Sensitivity C-Reactive Protein: A Meta-Analysis of Randomized Controlled Trials , 2014, Nutrients.
[57] D. Agrawal,et al. Vitamin D and inflammatory diseases , 2014, Journal of inflammation research.
[58] J. Powell,et al. Vitamin D and cardiovascular disease. , 2014, Circulation research.
[59] M. Holick,et al. Vitamin D and inflammation , 2014, Dermato-endocrinology.
[60] M. Boaz,et al. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. , 2013, Clinical nutrition.
[61] M. Dabbaghmanesh,et al. Serum IL-18 and hsCRP correlate with insulin resistance without effect of calcitriol treatment on type 2 diabetes. , 2013, Iranian journal of immunology : IJI.
[62] E. White,et al. Lifestyle Factors and Inflammation: Associations by Body Mass Index , 2013, PloS one.
[63] U. Querfeld. Vitamin D and inflammation , 2013, Pediatric Nephrology.
[64] Wei Li,et al. 25-hydroxyvitamin D3 ameliorates periodontitis by modulating the expression of inflammation-associated factors in diabetic mice , 2013, Steroids.
[65] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[66] C. Aranow. Vitamin D and the Immune System , 2011, Journal of Investigative Medicine.
[67] Afsar U. Ahmed. An overview of inflammation: mechanism and consequences , 2011, Frontiers in Biology.
[68] L. Brennan,et al. Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome. , 2011, Molecular nutrition & food research.
[69] N. Saidenberg-Kermanac’h,et al. Vitamin D and inflammation. , 2010, Joint, bone, spine : revue du rhumatisme.
[70] J. Coad,et al. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial , 2009, British Journal of Nutrition.
[71] D. Moher,et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.
[72] A. Pradhan,et al. Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. , 2007, Nutrition reviews.
[73] Jianfeng Xu,et al. Assembly of Inflammation-Related Genes for Pathway-Focused Genetic Analysis , 2007, PloS one.
[74] M. Holick. Vitamin D deficiency. , 2007, The New England journal of medicine.
[75] Raghu Kacker,et al. Random-effects model for meta-analysis of clinical trials: an update. , 2007, Contemporary clinical trials.
[76] S. Devaraj,et al. ATVB In Focus Nutrition and Atherosclerosis , 2006 .
[77] John Savill,et al. Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.
[78] M. Rubio-Ruíz,et al. Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease. , 2015, Interdisciplinary topics in gerontology.
[79] B. P. Gargari,et al. Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency , 2012, Journal of Endocrinological Investigation.